首页> 外国专利> Immunostimulant composition comprising at least one Toll-like receptor 7 or Toll-like receptor 8 agonist and a Toll-like receptor 4 agonist

Immunostimulant composition comprising at least one Toll-like receptor 7 or Toll-like receptor 8 agonist and a Toll-like receptor 4 agonist

机译:包含至少一种Toll样受体7或Toll样受体8激动剂和Toll样受体4激动剂的免疫刺激剂组合物

摘要

An immunostimulant composition (A) containing at least one toll-like receptor 7 or toll-like receptor 8 agonist (I) additionally contains a toll-like receptor 4 agonist (II). ACTIVITY : Immunostimulant; Antibacterial; Virucide; Hepatotropic; Antiinflammatory; Anti-HIV; Cytostatic; Antitubercular; Protozoacide. In tests in mice, subcutaneous injection of a composition containing 20 mu g Tat protein (as antigen), 5 mu g 4-amino-2-ethoxymethyl-alpha ,alpha -dimethyl-1H-imidazo-(4,5-c)-quinoline-1-ethanol(Ia)and 5 mu g ER804057 (IIa) gave an IgG1/IgG2a ratio 32 days later of 0.9, compared with 176.2 for Tat alone, 1.3 for Tat plus (Ia) and 3.5 for Tat plus (IIa), demonstrating that the combination of (Ia) and (IIa) orientated the immune response strongly towards the Th1 (rather than Th2) type. MECHANISM OF ACTION : Toll-like receptor 7 agonist; toll-like receptor 7 agonist; toll-like receptor 4 agonist.
机译:含有至少一种收费型受体7或收费型受体8激动剂(I)的免疫刺激组合物(A)还含有收费型受体4激动剂(II)。活动:免疫刺激剂;抗菌;杀病毒剂;肝消炎(药;抗艾滋病毒;细胞抑制抗结核原虫。在小鼠试验中,皮下注射了一种含有20μgTat蛋白(作为抗原),5μg4-氨基-2-乙氧基甲基-α,α-二甲基-1H-咪唑-(4,5-c)-喹啉-1-乙醇(Ia)和5微克ER804057(IIa)在32天后产生的IgG1 / IgG2a比为0.9,而单独使用Tat的为176.2,使用Iat的为1.3,使用Iat的3.5 ,表明(Ia)和(IIa)的组合使免疫反应强烈针对Th1型(而非Th2型)。作用机理:Toll样受体7激动剂; Toll样受体7激动剂; Toll样受体4激动剂。

著录项

  • 公开/公告号AU2004305276B2

    专利类型

  • 公开/公告日2010-07-01

    原文格式PDF

  • 申请/专利权人 SANOFI PASTEUR;

    申请/专利号AU20040305276

  • 发明设计人 JEAN HAENSLER;NICOLAS BURDIN;

    申请日2004-12-20

  • 分类号A61K31/4745;A61K31/685;A61K39;A61K39/39;A61K45/06;

  • 国家 AU

  • 入库时间 2022-08-21 18:41:54

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号